Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2007 (2007), Article ID 97654, 10 pages
http://dx.doi.org/10.1155/2007/97654
Research Article

Eisenia fetida Protease-III-1 Functions in Both Fibrinolysis and Fibrogenesis

1State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Baiao Pharmaceuticals Beijing C.L., Chinese Academy of Sciences, 15 Da Tun Road, Chao Yang District, Beijing 100101, China
2Graduate School, Chinese Academy of Sciences, Beijing 100039, China
3College of Life Science, South China Normal University, Guangzhou 510631, China

Received 10 December 2006; Accepted 19 March 2007

Academic Editor: Abdelali Haoudi

Copyright © 2007 Jing Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Mihara, H. Sumi, H. Mizumoto, T. Yoneta, R. Ikeda, and M. Maruyama, “Oral administration of earthworm powder as a possiblethrombolytic therapy,” in Recent Advances in Thrombosis and Fibrinolysis, K. Tanaka, Ed., pp. 287–298, Academic Press, New York, NY, USA, 1990.
  2. N. Nakajima, K. Ishihara, M. Sugimoto, H. Sumi, K. Mikuni, and H. Hamada, “Chemical modification of earthworm fibrinolytic enzyme with human serum albumin fragment and characterization of the protease as a therapeutic enzyme,” Bioscience, Biotechnology and Biochemistry, vol. 60, no. 2, pp. 293–300, 1996.
  3. J. Zhao, S. P. Qi, L. Li, J. Wu, and R.-Q. He, Earthworm Fibrinolytic Enzymes, vol. 30 of Studies in Natural Products Chemistry, Elsevier, North-Holland, The Netherlands, 2004.
  4. N. Nakajima, M. Sugimoto, and K. Ishihara, “Earthworm-serine protease: characterization, molecular cloning, and application of the catalytic functions,” Journal of Molecular Catalysis B: Enzymatic, vol. 23, no. 2–6, pp. 191–212, 2003. View at Publisher · View at Google Scholar
  5. C. Wu and R. Fan, “A rapid and effective thrombolytic agent: e-PA,” Acta Biophysica, vol. 2, p. 87, 1986.
  6. F. Wang, C. Wang, M. Li, L. Gui, J. Zhang, and W. Chang, “Purification, characterization and crystallization of a group of earthworm fibrinolytic enzymes from Eisenia fetida,” Biotechnology Letters, vol. 25, no. 13, pp. 1105–1109, 2003. View at Publisher · View at Google Scholar
  7. I. H. Cho, E. S. Choi, H. G. Lim, and H. H. Lee, “Purification and characterization of six fibrinolytic serine-proteases from earthworm Lumbricus rubellus,” Journal of Biochemistry and Molecular Biology, vol. 37, no. 2, pp. 199–205, 2004.
  8. T. Hraenjak, M. Popovic, and T. Bozic et al., “Fibrinolytic and anticoagulative activities from the earthworm, Eisenia fetida,” Comparative Biochemistry and Physiology—Part B: Biochemistry and Molecular Biology, vol. 119, no. 4, pp. 825–832, 1998. View at Publisher · View at Google Scholar
  9. Y.-H. Li, M. Zhang, J.-C. Wang, S. Zhang, J.-R. Liu, and Q. Zhang, “Effects of absorption enhancers on intestinal absorption of lumbrokinase,” Acta Pharmaceutica Sinica, vol. 41, no. 10, pp. 939–944, 2006.
  10. F. Wang, C. Wang, and M. Li et al., “Crystal structure of earthworm fibrinolytic enzyme component B: a novel, glycosylated two-chained trypsin,” Journal of Molecular Biology, vol. 348, no. 3, pp. 671–685, 2005. View at Publisher · View at Google Scholar · View at PubMed
  11. H. Sumi, N. Nakajima, and H. Mihara, “A very stable and potent fibrinolytic enzyme found in earthworm Lumbricus rubellus autolysate,” Comparative Biochemistry and Physiology—Part B: Biochemistry and Molecular Biology, vol. 106, no. 3, pp. 763–766, 1993. View at Publisher · View at Google Scholar
  12. N. Nakajima, H. Mihara, and H. Sumi, “Characterization of potent fibrinolytic enzymes in earthworm, Lumbricus rubellus,” Bioscience, Biotechnology and Biochemistry, vol. 57, no. 10, pp. 1726–1730, 1993.
  13. Q. Fan, C. Wu, and L. Li et al., “Some features of intestinal absorption of intact fibrinolytic enzyme III-1 from Lumbricus rubellus,” Biochimica et Biophysica Acta: General Subjects, vol. 1526, no. 3, pp. 286–292, 2001. View at Publisher · View at Google Scholar
  14. Y. S. Kim, M. K. Pyo, K. M. Park, B. S. Hahn, K. Y. Yang, and H. S. Yun-Choi, “Dose dependency of earthworm powder on antithrombotic and fibrinolytic effects,” Archives of Pharmacal Research, vol. 21, no. 4, pp. 374–377, 1998.
  15. N. Nakajima, M. Sugimoto, and K. Ishihara, “Stable earthworm serine proteases: application of the protease function and usefulness of the earthworm autolysate,” Journal of Bioscience and Bioengineering, vol. 90, no. 2, pp. 174–179, 2000. View at Publisher · View at Google Scholar
  16. J.-S. Yang and B.-G. Ru, “Purification and characterization of an SDS-activated fibrinolytic enzyme from Eisenia fetida,” Comparative Biochemistry and Physiology—Part B: Biochemistry and Molecular Biology, vol. 118, no. 3, pp. 623–631, 1997. View at Publisher · View at Google Scholar
  17. J. Zhao, R. Xiao, and J. He et al., “In situ localization and substrate specificity of earthworm protease-II and protease-III-1 from Eisenia fetida,” International Journal of Biological Macromolecules, vol. 40, no. 2, pp. 67–75, 2007. View at Publisher · View at Google Scholar · View at PubMed
  18. C. Wu, L. Li, J. Zhao, Q. Fan, W.-X. Tian, and R.-Q. He, “Effect of α2M on earthworm fibrinolytic enzyme III-1 from Lumbricus rubellus,” International Journal of Biological Macromolecules, vol. 31, no. 1–3, pp. 71–77, 2002. View at Publisher · View at Google Scholar
  19. J. Zhou, C. Wu, C. Wu, R. Fan, and R.-Q. He, “Characterization of activity and conformation of earthworm fibrinolytic enzyme III-1,” Journal of Biochemistry, Molecular Biology and Biophysics, vol. 2, no. 3, pp. 195–199, 1999.
  20. J. Zhao, L. Li, C. Wu, and R.-Q. He, “Hydrolysis of fibrinogen and plasminogen by immobilized earthworm fibrinolytic enzyme II from Eisenia fetida,” International Journal of Biological Macromolecules, vol. 32, no. 3–5, pp. 165–171, 2003. View at Publisher · View at Google Scholar
  21. J. X. Wu, X. Y. Zhao, R. Pan, and R.-Q. He, “Glycosylated trypsin-like proteases from earthworm Eisenia fetida,” International Journal of Biological Macromolecules, vol. 40, no. 5, pp. 399–406, 2007. View at Publisher · View at Google Scholar · View at PubMed
  22. R.-Q. He and J. Zhao, “A newly affinity chromatography technique for isolating monomer earthworm fibrinolytic enzyme,” 2005, Chinese National Patent: ZL02116747.8.
  23. J. Zhou, K. Fan, C. Wu, and R.-Q. He, “Assay of lumbrokinase with a chromophoric substrate,” Protein and Peptide Letters, vol. 4, no. 6, pp. 409–414, 1997.
  24. J. Zhou, K. Jiang, R.-Q. He, and Y. M. Han, “Assays of thrombin, hirudin and lumbrokinase with light scattering in the solution of fibrinogen,” Acta Biophysica Sinica, vol. 13, pp. 531–535, 1997.
  25. J. Sambrook, E. F. Fritsch, and T. Maniatis, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, New York, NY, USA, 2nd edition, 1989.
  26. R. F. Doolittle, K. W. Watt, B. A. Cottrell, D. D. Strong, and M. Riley, “The amino acid sequence of the α-chain of human fibrinogen,” Nature, vol. 280, no. 5722, pp. 464–468, 1979. View at Publisher · View at Google Scholar
  27. S. J. Friezner Degen, R. T. A. MacGillivray, and E. W. Davie, “Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin,” Biochemistry, vol. 22, no. 9, pp. 2087–2097, 1983. View at Publisher · View at Google Scholar
  28. J. Schaller, P. W. Moser, G. A. K. Dannegger-Müller, S. J. Rösselet, U. Kämpfer, and E. E. Rickli, “Complete amino acid sequence of bovine plasminogen. Comparison with human plasminogen,” European Journal of Biochemistry, vol. 149, no. 2, pp. 267–278, 1985. View at Publisher · View at Google Scholar
  29. X.-Q. Wu, C. Wu, and R.-Q. He, “Immobilized earthworm fibrinolytic enzyme III-1 with carbonyldiimidazole activated-agarose,” Protein and Peptide Letters, vol. 9, no. 1, pp. 75–80, 2002. View at Publisher · View at Google Scholar
  30. D. L. Spector, R. D. Goldman, and L. A. Leinwand, Cells: A Laboratory Manual, Cold Spring Harbor Laboratory Press, New York, NY, USA, 1998.
  31. C. Fuss, J. C. Palmaz, and E. A. Sprague, “Fibrinogen: structure, function, and surface interactions,” Journal of Vascular and Interventional Radiology, vol. 12, no. 6, pp. 677–682, 2001.
  32. D. Collen, “On the regulation and control of fibrinolysis. Edward Kowalski memorial lecture,” Thrombosis and Haemostasis, vol. 43, no. 2, pp. 77–89, 1980.
  33. G. Tsurupa and L. Medved, “Fibrinogen α C domains contain cryptic plasminogen and tPA binding sites,” Annals of the New York Academy of Sciences, vol. 936, pp. 328–330, 2001.
  34. E. T. Bach-Gansmo, S. Halvorsen, H. C. Godal, and O. H. Skjonsberg, “Degradation of the α-chain of fibrin by human neutrophil elastase reduces the stimulating effect of fibrin on plasminogen activation,” Thrombosis Research, vol. 75, no. 3, pp. 307–317, 1994. View at Publisher · View at Google Scholar
  35. C.-E. Dempfle, S. Argiriou, K. Kucher, H. Muller-Peltzer, K. Rubsamen, and D. L. Heene, “Analysis of fibrin formation and proteolysis during intravenous administration of ancrod,” Blood, vol. 96, no. 8, pp. 2793–2802, 2000.
  36. E. G. Bovill, R. P. Tracy, T. E. Hayes, R. J. Jenny, F. H. Bhushan, and K. G. Mann, “Evidence that meizothrombin is an intermediate product in the clotting of whole blood,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 6, pp. 754–758, 1995.
  37. H. W. Wang and C. F. Li, “Effect of earthworm plasminogen activator on coagulation and fibrinolysis systems,” Tianjin Medicine, vol. 19, pp. 73–75, 1991.
  38. P. B. Tracy, L. L. Eide, and K. G. Mann, “Human prothrombinase complex assembly and function on isolated peripheral blood cell populations,” Journal of Biological Chemistry, vol. 260, no. 4, pp. 2119–2124, 1985.
  39. Q. Dong, J. Qiao, and L.F. Shi, “The efficacy and safety of lumbrokinase capsule in treatment of cerebral infaretion,” Chinese New Drugs Journal, vol. 13, no. 3, pp. 257–260, 2004.
  40. L. R. Jing and G. Z. Xu, “Dynamics of fibrinolysis and hemostasis in ischemic stroke patients, and the effects of lumbrokinase on those dynamics,” Chinses Journal of New Drugs and Clinical Remedies, vol. 18, no. 1, pp. 48–50, 1999.
  41. S. Butenas, C. van't Veer, and K. G. Mann, ““Normal” thrombin generation,” Blood, vol. 94, no. 7, pp. 2169–2178, 1999.
  42. Y. P. Sun and R. Fan, “Fibrinolysis assay of lumbrokinase by intestinal administration in vivo,” Capital Medicine, vol. 5, p. 17, 1998.
  43. Y.-D. Park, J.-W. Kim, B.-G. Min, J.-W. Seo, and J.-M. Jeong, “Rapid purification and biochemical characteristics of lumbrokinase III from earthworm for use as a fibrinolytic agent,” Biotechnology Letters, vol. 20, no. 2, pp. 169–172, 1998. View at Publisher · View at Google Scholar
  44. C. P. Cannon, “Hirudin in acute myocardial infarction,” Journal of Thrombosis and Thrombolysis, vol. 1, no. 3, pp. 259–267, 1995. View at Publisher · View at Google Scholar
  45. R. M. Califf, S. Mantell, and C. Westawski et al., “Experience with the use of tPA in the treatment of acute myocardial infarction,” Annals of Emergency Medicine, vol. 17, no. 11, pp. 1176–1189, 1988. View at Publisher · View at Google Scholar
  46. B. Wiman, “Primary structure of peptides released during activation of human plasminogen by urokinase,” European Journal of Biochemistry, vol. 39, no. 1, pp. 1–9, 1973. View at Publisher · View at Google Scholar
  47. C. Duboscq, V. Genoud, M. F. Parborell, and L. C. Kordich, “Impaired clot lysis by rt-PA catalyzed mini-plasminogen activation,” Thrombosis Research, vol. 86, no. 6, pp. 505–513, 1997. View at Publisher · View at Google Scholar
  48. E. G. Bovill, R. P. Tracy, and T. E. Hayes, “Evidence that meizothrombin is an intermediate product in the clotting of whole blood,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 6, pp. 754–758, 1995 .